Effects of program scale-up on time to resolution for patients with abnormal screening mammography results

Cancer Causes & Control : CCC
Simon Craddock LeeJasmin A Tiro

Abstract

Effects of geographic program expansion to rural areas on screening program outcomes are understudied. We sought to determine whether time-to-resolution (TTR) varied significantly by service delivery time period, location, and participant characteristics across 19 North Texas counties. We calculated proportions undergoing diagnostic follow-up and resolved ≤ 60 days. We calculated median TTR for each time period and abnormal result BI-RADS 0, 4, 5. Cox proportional hazards regressions estimated time period and patient characteristic effects on TTR. Wilcoxon rank sum tests evaluated whether TTR differed between women who did or did not transfer between counties for services. TTR ranged from 14 to 17 days for BI-RADs 0, 4, and 5; 12.4% transferred to a different county, resulting in longer median TTR (26 vs. 16 days; p < .001). Of those completing follow-up, 92% were resolved ≤ 60 days (median 15 days). For BI-RAD 3, TTR was 208 days (including required 180 day waiting period). Follow-up was significantly lower for women with BI-RAD 3 (59% vs. 96%; p < .0001). Expansion maintained timely service delivery, increasing access to screening among rural, uninsured women. Policies adding a separate quality metric for BI-RAD 3 could encou...Continue Reading

References

Mar 1, 1996·Preventive Medicine·L S CaplanB K Edwards
Jan 1, 1996·Health Affairs·J C Robinson, L P Casalino
Mar 24, 2005·Psycho-oncology·J BrettJ Austoker
Apr 6, 2006·Cancer Causes & Control : CCC·Lucy A PeipinsZahava Berkowitz
May 21, 2008·Patient Education and Counseling·Jennifer D AllenRoberta E Goldman
Mar 3, 2010·Medical Care·Elena B ElkinDeborah Schrag
Apr 16, 2010·International Journal of Technology Assessment in Health Care·Pamela WhittenLianh Nguyen
Apr 12, 2011·European Journal of Radiology·Yao-Lung KuoTsai-Wang Chang
Aug 23, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Stephen H TaplinJane Zapka
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Electra D PaskettUNKNOWN Ohio Patient Navigation Research Program
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Peter C RaichUNKNOWN Denver Patient Navigation Research Program
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Donald J DudleyAmelie Ramirez
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tracy A BattagliaKaren M Freund
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Heather J HoffmanSteven R Patierno
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kristen J WellsRichard G Roetzheim
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Talar W MarkossianElizabeth A Calhoun
Jan 30, 2013·Medical Care·L Elizabeth GoldmanUNKNOWN Breast Cancer Surveillance Consortium
Jul 3, 2013·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Ana P Martinez-DonateXinyi Wang
Jan 21, 2014·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Mira L KatzElectra D Paskett
Mar 13, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·Lori J GoldsteinDelinda Pendleton
Mar 29, 2014·Journal of Oncology Practice·Mathew GeorgeAmy Prawira
Aug 8, 2014·Cancer·Brandie YancyAmy DeGroff
Oct 15, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica L Krok-SchoenElectra D Paskett
Dec 17, 2014·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Douglas M PostElectra D Paskett
Apr 30, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Saber Azami-AghdashAhmad Moosavi
May 10, 2015·Journal of the National Cancer Institute·Elisabeth F BeaberUNKNOWN Population-based Research Optimizing Screening through Personalized Regimens Consortium
Aug 13, 2015·Implementation Science : IS·Andrew J MilatSally Redman
Oct 27, 2015·JAMA : the Journal of the American Medical Association·Kevin C OeffingerUNKNOWN American Cancer Society
Dec 15, 2015·Journal of General Internal Medicine·Anna N A TostesonUNKNOWN PROSPR consortium
Jul 13, 2016·Translational Behavioral Medicine·Simon J Craddock LeeJasmin A Tiro
Dec 25, 2016·Evaluation and Program Planning·Stephen J InrigSimon J Craddock Lee
Mar 13, 2018·Preventive Medicine Reports·Simon J Craddock LeeJasmin A Tiro

❮ Previous
Next ❯

Citations

Nov 10, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rasmi G NairCelette Sugg Skinner

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

Moncrief
NBCCEDP
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.